Biolegio
Building the Bases of Discovery.
Building the Bases of Discovery.
**Biolegio** is a pioneering company that has been in the business of custom oligonucleotide synthesis for over two decades. It has been instrumental in fostering research and development in the fields of life science and molecular diagnostics. With a commitment to advancing scientific progress and innovation, Biolegio aims to be the trusted partner for oligo supply. The company operates within the industries of Analytics, Biotechnology, and Health Care, and was founded in 1996. While specific details about its headquarters and recent investments are not available at this time, Biolegio's dedication to empowering researchers worldwide makes it an intriguing prospect for potential investors.
There is no investment information
No recent news or press coverage available for Biolegio.
We care about your data, and we'd love to use cookies make your experience better.
